Difference between revisions of "PCC TC Face to Face July 22 26, 2019 Minutes"
Jump to navigation
Jump to search
Line 27: | Line 27: | ||
***In Person: Lori Fourquet, Derek, | ***In Person: Lori Fourquet, Derek, | ||
***Via Webex: Michael Nusbaum | ***Via Webex: Michael Nusbaum | ||
− | ** | + | **IHE PCC TC questions |
− | + | ***1)Scope of workflow | |
+ | ***2)Benefits for vendor (risks | ||
+ | ***3)Marketing | ||
+ | **Next steps | ||
+ | ***IHE PCC TC needs more detail about this proposal. | ||
+ | ***Is there any additional stake holder ? | ||
+ | ***Who is responsible of what (HL7/IHE)? | ||
== '''Tuesday July 23, 2019''' == | == '''Tuesday July 23, 2019''' == |
Revision as of 08:20, 23 July 2019
Monday July 22, 2019
- Attendees
- In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- Review Anti-trust and Patent Policy
- Format codes
- Format codes IHE and HL7 have their own format codes
- There is a lot of confusion for a vendor perspective between format codes and template ID
- Shall PCC work on a profile to manage this ?
- Agenda update see PCC_TC_Face_to_Face_July_22-26,_2019
- DCP and CDA-DSS (review of public comments)
- IPS-International Patient Summary (Profil proposal)
- Website [3]
- Attendees: same +
- In Person: Lori Fourquet, Derek,
- Via Webex: Michael Nusbaum
- IHE PCC TC questions
- 1)Scope of workflow
- 2)Benefits for vendor (risks
- 3)Marketing
- Next steps
- IHE PCC TC needs more detail about this proposal.
- Is there any additional stake holder ?
- Who is responsible of what (HL7/IHE)?
Tuesday July 23, 2019
- Attendees
- In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
- Via Webex: Emma Jones (Allscripts)
- DCP and CDA-DSS (review of public comments)
- DCP public comments
- C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-46: Persuasive
- C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff
- C-47, C-48: Non persuasive
- C-49, C-52: Hold for now
- C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
- C-25 to C-28: persuasive, split the use cases to simplify the diagram to include the additional subscribe transactions
- CDA-DSS public comments
- C-01 to C-03, C-05 to C-10: persuasive
- C-04: non persuasive
- DCP public comments